Basic Information
| LncRNA/CircRNA Name | LINC01061 |
| Synonyms | NA |
| Region | GRCh38_1:29554-31109 |
| Ensemble | |
| Refseq | NR_037596 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cholangiocarcinoma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay, RIP |
| Sample | CCA cell lines (Huh-28, HuCCT1, KKU-214,RBE,MMNK-1) |
| Expression Pattern | up-regulated |
| Function Description | LINC01061 levels were significantly upregulated in CCA cell lines, especially in KKU-214 and RBE cells. |
| Pubmed ID | 30967271 |
| Year | 2019 |
| Title | LncRNA LINC01061 sponges miR-612 to regulate the oncogenic role of SEMA4D in cholangiocarcinoma. |
External Links
| Links for LINC01061 | GenBank HGNC NONCODE |
| Links for cholangiocarcinoma | OMIM COSMIC |